Starting from the transcriptional and metabolic reprogramming mediated by FOXA1 and FOXA2 in HCC, we expect that more targeted therapies for HCC will be proposed to achieve more precise and effective targets. Here, FOXA2 is linked to hepatocellular carcinoma.